“Cost-Consequence Analysis of Three Different Diagnostic Strategies in the First- and Second-Line Treatment of Locally Advanced or Metastatic Non-Small-Cell Lung Cancer”. Farmeconomia. Health Economics and Therapeutic Pathways 19, no. 1 (May 23, 2018). Accessed December 28, 2025. https://journals.seedstm.com/index.php/FE/article/view/1354.